Effects of bisphosphonates treatment on BMD in patients with postmenopausal osteoporosis

被引：0
|
作者：
Lin, Hua [1 ]
Bao, Li-hua [1 ]
Han, Zu-bin [1 ]
Chen, Xin [1 ]
机构：
[1] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Ctr Res Metab Bone Dis, Nanjing, Peoples R China
来源：
BONE | 2008年 / 43卷
关键词：
D O I：
10.1016/j.bone.2008.07.159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Bisphosphonates for the treatment of postmenopausal osteoporosis: Clinical studies of etidronate and alendronate
    Harris, ST
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 : 11 - 16
  • [22] The role of bisphosphonates in the prevention of postmenopausal osteoporosis
    Ambrosini, A
    Marchesoni, D
    Mozzanega, B
    WOMEN'S HEALTH IN THE 2000: FROM REPRODUCTION TO MENOPAUSE, 1999, : 133 - 140
  • [23] EFFECTS OF ODANACATIB ON BMD AND OVERALL SAFETY IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Smith, E.
    Chapurlat, R.
    Bonnick, S.
    De Villiers, T.
    Odio, A.
    Palacios, S.
    Scott, B.
    De Tilleghem, Le Bailly C.
    Dasilva, C.
    Leung, A.
    Gurner, D.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 29 - 29
  • [24] Drug insight: bisphosphonates for postmenopausal osteoporosis
    Chapurlat, RD
    Delmas, PD
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (04): : 211 - 219
  • [25] Effects of Odanacatib On BMD and Overall Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate
    Chapurlat, Roland
    Bonnick, Sydney
    De Villiers, Tobias
    Odio, Alberto
    Palacios, Santiago
    Scott, Boyd
    De Tilleghem, Celine Le Bailly
    DaSilva, Carolyn
    Leung, Albert
    Gurner, Deborah
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S312 - S312
  • [26] THE METABOLIC EFFECTS OF TREATMENT WITH CALCITRIOL IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    RECKER, RR
    GALLAGHER, JC
    HEANEY, RP
    CLINICAL RESEARCH, 1984, 32 (02): : A406 - A406
  • [27] Drug Insight: bisphosphonates for postmenopausal osteoporosis
    Roland D Chapurlat
    Pierre D Delmas
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 211 - 219
  • [28] EFFECTS OF ODANACATIB ON BMD AND OVERALL SAFETY IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Chen, J-F
    De Villiers, T.
    Bonnick, S.
    Chapurlat, R.
    Odio, A.
    Palacios, S.
    Scott, B.
    De Tilleghem, C. Le Bailly
    DaSilva, C.
    Leung, A.
    Gurner, D.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S753 - S754
  • [29] Use of bisphosphonates in the management of postmenopausal osteoporosis
    Papapoulos, Socrates E.
    BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW, 2011, 1218 : 15 - 32
  • [30] Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis
    Ebina, Kosuke
    Hirao, Makoto
    Tsuboi, Hideki
    Nagayama, Yoshio
    Kashii, Masafumi
    Kaneshiro, Shoichi
    Miyama, Akira
    Nakaya, Hiroyuki
    Kunugiza, Yasuo
    Okamura, Gensuke
    Etani, Yuki
    Takami, Kenji
    Goshima, Atsushi
    Nakata, Ken
    BONE, 2020, 140
12345